Tert-butyl 2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]-8-oxo-9H-purine-7-carboxylate;2,2-difluoro-N-[2-[1-[(2-fluorophenyl)methyl]-5-(1,3-oxazol-2-yl)pyrazol-3-yl]-6-oxo-1H-pyrimidin-5-yl]-1-methylcyclopropane-1-carboxamide
C45H37F4N13O7 — CID 158008375
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]-8-oxo-9H-purine-7-carboxylate;2,2-difluoro-N-[2-[1-[(2-fluorophenyl)methyl]-5-(1,3-oxazol-2-yl)pyrazol-3-yl]-6-oxo-1H-pyrimidin-5-yl]-1-methylcyclopropane-1-carboxamide
Tert-butyl 2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]-8-oxo-9H-purine-7-carboxylate;2,2-difluoro-N-[2-[1-[(2-fluorophenyl)methyl]-5-(1,3-oxazol-2-yl)pyrazol-3-yl]-6-oxo-1H-pyrimidin-5-yl]-1-methylcyclopropane-1-carboxamide (PubChem CID 158008375) has the molecular formula C45H37F4N13O7 and a molecular weight of 947.87 g/mol. Its IUPAC name is tert-butyl 2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]-8-oxo-9H-purine-7-carboxylate;2,2-difluoro-N-[2-[1-[(2-fluorophenyl)methyl]-5-(1,3-oxazol-2-yl)pyrazol-3-yl]-6-oxo-1H-pyrimidin-5-yl]-1-methylcyclopropane-1-carboxamide.
Molecular Properties
| Compound Name | Tert-butyl 2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]-8-oxo-9H-purine-7-carboxylate;2,2-difluoro-N-[2-[1-[(2-fluorophenyl)methyl]-5-(1,3-oxazol-2-yl)pyrazol-3-yl]-6-oxo-1H-pyrimidin-5-yl]-1-methylcyclopropane-1-carboxamide |
|---|---|
| PubChem CID | 158008375 |
| Molecular Formula | C45H37F4N13O7 |
| Molecular Weight | 947.87 g/mol |
| Exact Mass | 947.29 |
| IUPAC Name | tert-butyl 2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]-8-oxo-9H-purine-7-carboxylate;2,2-difluoro-N-[2-[1-[(2-fluorophenyl)methyl]-5-(1,3-oxazol-2-yl)pyrazol-3-yl]-6-oxo-1H-pyrimidin-5-yl]-1-methylcyclopropane-1-carboxamide |
| SMILES | CC(C)(C)OC(=O)n1c(=O)[nH]c2nc(-c3cc(-c4ccon4)n(Cc4ccccc4F)n3)ncc21.CC1(C(=O)Nc2cnc(-c3cc(-c4ncco4)n(Cc4ccccc4F)n3)[nH]c2=O)CC1(F)F |
| InChI | InChI=1S/C23H20FN7O4.C22H17F3N6O3/c1-23(2,3)35-22(33)31-18-11-25-19(26-20(18)27-21(31)32)16-10-17(15-8-9-34-29-15)30(28-16)12-13-6-4-5-7-14(13)24;1-21(11-22(21,24)25)20(33)28-15-9-27-17(29-18(15)32)14-8-16(19-26-6-7-34-19)31(30-14)10-12-4-2-3-5-13(12)23/h4-11H,12H2,1-3H3,(H,25,26,27,32);2-9H,10-11H2,1H3,(H,28,33)(H,27,29,32) |
| InChIKey | FEOSJLDOQYEINO-UHFFFAOYSA-N |
| XLogP | 7.07 |
| TPSA | 252.42 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 69 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 947.87 |
| LogP ≤ 5 | 7.07 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158008375 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.